Compounded GLP-1 Receptor Agonists Remain Widely Available WEDNESDAY, July 22, 2026 -- Despite the end of nationwide shortages of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the market for compounded GLP-1 RA alternatives
Brian Vandahl, senior vice president of Novos Global Research Technologies, said the goal of the partnership is to find new treatments in the GLP-1 space that can be dosed less frequently, potentially reducing patient burden and costs
We offer a range of IV infusions
Incorporating these natural glp 1 receptor agonists through diet or supplements can be a sustainable approach to metabolic wellness
Components: Tirzepatide (or semaglutide): Primary weight loss driver targeting appetite, insulin, and glucose metabolism CJC-1295 with ipamorelin : Growth hormone support for lean mass preservation, sleep improvement, and additional fat oxidation Rationale for menopausal women: The GLP-1 component addresses the insulin resistance and appetite dysregulation caused by estrogen decline, while the GH secretagogue preserves muscle mass that would otherwise be lost during caloric restriction
Great prices as well for someone without health insurance." Complete the intake form Answer a few questions about your health history, goals, and what you've tried before
